Jeremiah M. Scharf, MD, Ph.D.

Board Member

Assistant Professor of Neurology, Harvard Medical School

Director, Tic Disorders Clinic, Department of Neurology, Massachusetts General Hospital

Clinical Research Scientist,

Psychiatric & Neurodevelopmental Genetics Unit

Center for Human Genetic Research

Massachusetts General Hospital

Dr. Jeremiah Scharf is a behavioral neurologist and tic disorder specialist as well as a clinical researcher in molecular genetics. He specializes clinically in disorders that lie at the interface between neurology and psychiatry, particularly Tourette Syndrome (TS) and related conditions. His research efforts focus on the genetic underpinnings of TS as well as exploration of heritable subphenotypes of this disorder that might prove useful for future research studies and clinical trials. 

Dr. Scharf completed his BS in Molecular Biophysics and Biochemistry from Yale University, his MD from the Harvard-MIT Division of Health Sciences and Technology at Harvard Medical School, and his Ph.D. in Neurobiology from Harvard University, where he studied neurogenetics under Dr. Louis Kunkel. Following his neurology residency at Massachusetts General and Brigham and Women's Hospitals, Dr. Scharf completed subspecialty training in behavioral neurology and neuropsychiatry at the Brigham Behavioral Neurology Group as well as a research fellowship in the PNGU under Dr. David Pauls. 

Dr. Scharf is a member of the Steering Committee for the TSA International Consortium for Genetics (TSAICG), a team of clinicians and molecular geneticists dedicated to identifying susceptibility genes for TS. He has received research grants from the Tourette Syndrome Association, American Academy of Neurology Foundation, and the National Institutes for Mental Health (NIMH).